COMPANY INTELLIGENCEWhat the linked records show
MedtechLedger currently links 2 FDA records to the applicant name GE Healthcare. The collection includes 1 510(k) clearance. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Nov 21, 2025 to Jan 8, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LLZ appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P130020, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 500 W. Monroe St., Chicago, IL, 60661, US. Recorded on K253639, decision dated Jan 8, 2026.
Device categories in this collection
System, Image Processing, Radiological; Digital breast tomosynthesis.
Changes described in PMA records
FDA’s recorded scope: Approval for Senographe Pristina 3D that includes an update to the DBT reconstruction algorithm to enhance image quality using deep learning algorithms to correct sparse view artifacts, compensate for patient motion artifacts and enhance the visibility of soft tissue lesions within the 2D synthetic image.
Nov 21, 2025 · Normal 180 Day TrackSubsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.